The risk or severity of adverse effects can be increased when Streptokinase is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Hydralazine. Moclobemide may increase the hypotensive activities of Ramipril. Heparin may increase the hyperkalemic activities of Ramipril. The risk or severity of adverse effects can be increased when Clozapine is combined with Ramipril. The serum concentration of Methallenestril can be decreased when it is combined with Ramipril. Ramipril may increase the hypotensive activities of Polythiazide. Tizanidine may increase the hypotensive activities of Ramipril. Isocarboxazid may increase the hypotensive activities of Ramipril. The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Temsirolimus. The serum concentration of Dihydroergotamine can be increased when it is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Clonidine. The risk or severity of adverse effects can be increased when Ramipril is combined with Triamterene. 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypotensive activities of Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Isoxsuprine. The serum concentration of Nefazodone can be increased when it is combined with Ramipril. Ramipril may increase the hypotensive activities of Unoprostone. Icatibant may decrease the antihypertensive activities of Ramipril. Carbaspirin calcium may decrease the antihypertensive activities of Ramipril. The risk or severity of adverse effects can be increased when Barnidipine is combined with Ramipril. The risk or severity of adverse effects can be increased when Pramipexole is combined with Ramipril. Ramipril may increase the hypotensive activities of Hydroflumethiazide. The risk or severity of adverse effects can be increased when Cilnidipine is combined with Ramipril. Nicorandil may increase the hypotensive activities of Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Nimodipine. Tolvaptan may increase the hyperkalemic activities of Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Furosemide. The serum concentration of Atorvastatin can be increased when it is combined with Ramipril. The serum concentration of Cyclosporine can be increased when it is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Masoprocol. The risk or severity of adverse effects can be increased when Linagliptin is combined with Ramipril. The serum concentration of Triazolam can be increased when it is combined with Ramipril. Rasagiline may increase the hypotensive activities of Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Isoxicam. The risk or severity of adverse effects can be increased when Ramipril is combined with Indobufen. The risk or severity of adverse effects can be increased when Ramipril is combined with Rofecoxib. The risk or severity of adverse effects can be increased when Ramipril is combined with Empagliflozin. The risk or severity of adverse effects can be increased when Olmesartan is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Balsalazide. Mirodenafil may increase the antihypertensive activities of Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Naproxen. The risk or severity of adverse effects can be increased when Ramipril is combined with Minoxidil. The risk or severity of adverse effects can be increased when Ramipril is combined with Methyldopa. The risk or severity of adverse effects can be increased when Ramipril is combined with Indoprofen. The serum concentration of Delavirdine can be decreased when it is combined with Ramipril. The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Ramipril. Ramipril may increase the hypotensive activities of Travoprost. Mebanazine may increase the hypotensive activities of Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Nitroprusside. The risk or severity of adverse effects can be increased when Ramipril is combined with Amlodipine. Ramipril may increase the hypotensive activities of Nilvadipine. The metabolism of Ramipril can be increased when combined with St. John's Wort. The risk or severity of adverse effects can be increased when Ramipril is combined with Oxaprozin. Nadroparin may increase the hyperkalemic activities of Ramipril. The serum concentration of Ramipril can be decreased when it is combined with Tipranavir. The serum concentration of Theophylline can be decreased when it is combined with Ramipril. The risk or severity of adverse effects can be increased when Carbetocin is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Curcumin. Thiamylal may increase the hypotensive activities of Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Fenbufen. Canagliflozin may increase the hyperkalemic activities of Ramipril. Pargyline may increase the hypotensive activities of Ramipril. Ramipril may increase the hypotensive activities of Efonidipine. The risk or severity of adverse effects can be increased when Ramipril is combined with Metipranolol. The risk or severity of adverse effects can be increased when Ramipril is combined with Zomepirac. The risk or severity of adverse effects can be increased when Ramipril is combined with Phenylbutazone. Ramipril may increase the hypotensive activities of Ticrynafen. Ramipril may increase the hypotensive activities of Tetrahydropalmatine. The risk or severity of adverse effects can be increased when Ramipril is combined with Azapropazone. The risk or severity of adverse effects can be increased when Ramipril is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Ramipril is combined with Acebutolol. The risk or severity of adverse effects can be increased when Tamsulosin is combined with Ramipril. Toloxatone may increase the hypotensive activities of Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Mizoribine. Octamoxin may increase the hypotensive activities of Ramipril. Furazolidone may increase the hypotensive activities of Ramipril. The risk or severity of adverse effects can be increased when Amiodarone is combined with Ramipril. Ramipril may increase the hypotensive activities of Cryptenamine. Ramipril may increase the hypotensive activities of Treprostinil. Ramipril may increase the hypotensive activities of Phentolamine. Nialamide may increase the hypotensive activities of Ramipril. The risk or severity of adverse effects can be increased when Fimasartan is combined with Ramipril. Hexobarbital may increase the hypotensive activities of Ramipril. The risk or severity of adverse effects can be increased when Tretinoin is combined with Ramipril. The risk or severity of adverse effects can be increased when Everolimus is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Duvelisib. The risk or severity of adverse effects can be increased when Ramipril is combined with Naftifine. The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Ramipril. Ramipril may increase the hypotensive activities of Bepridil. Ramipril may increase the myelosuppressive activities of Azathioprine. The risk or severity of adverse effects can be increased when Ramipril is combined with Seratrodast. Ramipril may increase the hypotensive activities of Sitaxentan. The metabolism of Ramipril can be increased when combined with Carbamazepine. Ramipril may increase the hypotensive activities of Dorzolamide. The risk or severity of adverse effects can be increased when Valsartan is combined with Ramipril. The risk or severity of adverse effects can be increased when Saprisartan is combined with Ramipril. The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Ramipril. The risk or severity of adverse effects can be increased when Forasartan is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Papaverine. The serum concentration of Estradiol can be decreased when it is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Semapimod. The risk or severity of adverse effects can be increased when Ramipril is combined with Castanospermine. Tadalafil may increase the antihypertensive activities of Ramipril. The serum concentration of Aminophylline can be decreased when it is combined with Ramipril. The risk or severity of adverse effects can be increased when Imidapril is combined with Ramipril. The risk or severity of adverse effects can be increased when Tasosartan is combined with Ramipril. Ramipril may increase the hypotensive activities of Alprenolol. The risk or severity of adverse effects can be increased when Ramipril is combined with Captopril. Ramipril may increase the hypotensive activities of Niguldipine. The risk or severity of adverse effects can be increased when Ramipril is combined with Adapalene. The risk or severity of adverse effects can be increased when Ramipril is combined with Pirfenidone. The risk or severity of adverse effects can be increased when Ramipril is combined with Evening primrose oil. Nitroaspirin may decrease the antihypertensive activities of Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Tranilast. Benmoxin may increase the hypotensive activities of Ramipril. The serum concentration of Diethylstilbestrol can be decreased when it is combined with Ramipril. The serum concentration of Opipramol can be increased when it is combined with Ramipril. Ramipril may increase the hypotensive activities of Lofexidine. The risk or severity of adverse effects can be increased when Ramipril is combined with Suprofen. The serum concentration of Dienestrol can be decreased when it is combined with Ramipril. Moxonidine may increase the hypotensive activities of Ramipril. Ramipril may increase the hypotensive activities of Fenoldopam. The risk or severity of adverse effects can be increased when Ramipril is combined with Dipyridamole. The risk or severity of adverse effects can be increased when Ramipril is combined with Olopatadine. Ramipril may increase the hypotensive activities of Candoxatril. Indoramin may increase the hypotensive activities of Ramipril. The serum concentration of Clomipramine can be increased when it is combined with Ramipril. The serum concentration of Amineptine can be increased when it is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Iron.